We read the paper by Manar et al. 1 with interest. They showed a decreased frequency of the GSTP1 105 Val/Val genotype in infants with chronic lung disease (CLD) compared with term control infants. We have also been investigating the association of various gene polymorphisms in neonatal disorders, including the 105 Ile>Val polymorphism in exon 5 of the GSTP1 gene.
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Infants born at less than 32 weeks gestation were studied, 104 who had CLD and remained oxygen dependent at 36 weeks postmenstrual age, and 70 similar preterm controls without CLD. All were Caucasian. DNA was extracted from buccal cells using standard techniques. The 105 Ile>Val polymorphism was detected as previously described by Rodriguez-Frias et al. 2 The distribution of genotypes according to CLD or control was not statistically significantly different (p ¼ 0.09) ( Table 1) , although the Val/Val genotype was more commonly observed in the CLD group.
Comparing our data with that of Manar et al. (Table 2) showed no statistically significantly differences in distribution of genotypes in cases (p ¼ 0.15) or in controls (p ¼ 0.07) between the two data sets. Each data set is compatible with the other.
The reason for the differences in findings is most likely to be the small numbers in both data sets. An alternative explanation might be the use of preterm controls as the polymorphism in question is associated with early pregnancy loss and pre-eclampsia. 3, 4 Larger or pooled data sets will be needed before the role, if any, of GSTP1 polymorphisms can be assessed in CLD. 
